Cargando…

Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?

Actin-related protein 2/3 complex subunit 1B (ARPC1B) deficiency is a recently described inborn error of immunity (IEI) presenting with combined immunodeficiency and characterized by recurrent infections and thrombocytopenia. Manifestations of immune dysregulation, including colitis, vasculitis, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiriaco, Maria, Ursu, Giorgiana Madalina, Amodio, Donato, Cotugno, Nicola, Volpi, Stefano, Berardinelli, Francesco, Pizzi, Simone, Cifaldi, Cristina, Zoccolillo, Matteo, Prigione, Ignazia, Di Cesare, Silvia, Giancotta, Carmela, Anastasio, Elisa, Rivalta, Beatrice, Pacillo, Lucia, Zangari, Paola, Fiocchi, Alessandro G., Diociaiuti, Andrea, Bruselles, Alessandro, Pantaleoni, Francesca, Ciolfi, Andrea, D’Oria, Valentina, Palumbo, Giuseppe, Gattorno, Marco, El Hachem, Maya, de Villartay, Jean-Pierre, Finocchi, Andrea, Palma, Paolo, Rossi, Paolo, Tartaglia, Marco, Aiuti, Alessandro, Antoccia, Antonio, Di Matteo, Gigliola, Cancrini, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372879/
https://www.ncbi.nlm.nih.gov/pubmed/35967303
http://dx.doi.org/10.3389/fimmu.2022.919237
_version_ 1784767484616769536
author Chiriaco, Maria
Ursu, Giorgiana Madalina
Amodio, Donato
Cotugno, Nicola
Volpi, Stefano
Berardinelli, Francesco
Pizzi, Simone
Cifaldi, Cristina
Zoccolillo, Matteo
Prigione, Ignazia
Di Cesare, Silvia
Giancotta, Carmela
Anastasio, Elisa
Rivalta, Beatrice
Pacillo, Lucia
Zangari, Paola
Fiocchi, Alessandro G.
Diociaiuti, Andrea
Bruselles, Alessandro
Pantaleoni, Francesca
Ciolfi, Andrea
D’Oria, Valentina
Palumbo, Giuseppe
Gattorno, Marco
El Hachem, Maya
de Villartay, Jean-Pierre
Finocchi, Andrea
Palma, Paolo
Rossi, Paolo
Tartaglia, Marco
Aiuti, Alessandro
Antoccia, Antonio
Di Matteo, Gigliola
Cancrini, Caterina
author_facet Chiriaco, Maria
Ursu, Giorgiana Madalina
Amodio, Donato
Cotugno, Nicola
Volpi, Stefano
Berardinelli, Francesco
Pizzi, Simone
Cifaldi, Cristina
Zoccolillo, Matteo
Prigione, Ignazia
Di Cesare, Silvia
Giancotta, Carmela
Anastasio, Elisa
Rivalta, Beatrice
Pacillo, Lucia
Zangari, Paola
Fiocchi, Alessandro G.
Diociaiuti, Andrea
Bruselles, Alessandro
Pantaleoni, Francesca
Ciolfi, Andrea
D’Oria, Valentina
Palumbo, Giuseppe
Gattorno, Marco
El Hachem, Maya
de Villartay, Jean-Pierre
Finocchi, Andrea
Palma, Paolo
Rossi, Paolo
Tartaglia, Marco
Aiuti, Alessandro
Antoccia, Antonio
Di Matteo, Gigliola
Cancrini, Caterina
author_sort Chiriaco, Maria
collection PubMed
description Actin-related protein 2/3 complex subunit 1B (ARPC1B) deficiency is a recently described inborn error of immunity (IEI) presenting with combined immunodeficiency and characterized by recurrent infections and thrombocytopenia. Manifestations of immune dysregulation, including colitis, vasculitis, and severe dermatitis, associated with eosinophilia, hyper-IgA, and hyper-IgE are also described in ARPC1B-deficient patients. To date, hematopoietic stem cell transplantation seems to be the only curative option for patients. ARPC1B is part of the actin-related protein 2/3 complex (Arp2/3) and cooperates with the Wiskott–Aldrich syndrome protein (WASp) in the regulation of the actin cytoskeleton remodeling and in driving double-strand break clustering for homology-directed repair. In this study, we aimed to investigate radiosensitivity (RS) in ARPC1B-deficient patients to assess whether it can be considered an additional disease trait. First, we performed trio-based next-generation-sequencing studies to obtain the ARPC1B molecular diagnosis in our index case characterized by increased RS, and then we confirmed, using three different methods, an increment of radiosensitivity in all enrolled ARPC1B-deficient patients. In particular, higher levels of chromatid-type aberrations and γH2AX foci, with an increased number of cells arrested in the G2/M-phase of the cell cycle, were found in patients’ cells after ionizing radiation exposition and radiomimetic bleomycin treatment. Overall, our data suggest increased radiosensitivity as an additional trait in ARPC1B deficiency and support the necessity to investigate this feature in ARPC1B patients as well as in other IEI with cytoskeleton defects to address specific clinical follow-up and optimize therapeutic interventions.
format Online
Article
Text
id pubmed-9372879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93728792022-08-13 Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? Chiriaco, Maria Ursu, Giorgiana Madalina Amodio, Donato Cotugno, Nicola Volpi, Stefano Berardinelli, Francesco Pizzi, Simone Cifaldi, Cristina Zoccolillo, Matteo Prigione, Ignazia Di Cesare, Silvia Giancotta, Carmela Anastasio, Elisa Rivalta, Beatrice Pacillo, Lucia Zangari, Paola Fiocchi, Alessandro G. Diociaiuti, Andrea Bruselles, Alessandro Pantaleoni, Francesca Ciolfi, Andrea D’Oria, Valentina Palumbo, Giuseppe Gattorno, Marco El Hachem, Maya de Villartay, Jean-Pierre Finocchi, Andrea Palma, Paolo Rossi, Paolo Tartaglia, Marco Aiuti, Alessandro Antoccia, Antonio Di Matteo, Gigliola Cancrini, Caterina Front Immunol Immunology Actin-related protein 2/3 complex subunit 1B (ARPC1B) deficiency is a recently described inborn error of immunity (IEI) presenting with combined immunodeficiency and characterized by recurrent infections and thrombocytopenia. Manifestations of immune dysregulation, including colitis, vasculitis, and severe dermatitis, associated with eosinophilia, hyper-IgA, and hyper-IgE are also described in ARPC1B-deficient patients. To date, hematopoietic stem cell transplantation seems to be the only curative option for patients. ARPC1B is part of the actin-related protein 2/3 complex (Arp2/3) and cooperates with the Wiskott–Aldrich syndrome protein (WASp) in the regulation of the actin cytoskeleton remodeling and in driving double-strand break clustering for homology-directed repair. In this study, we aimed to investigate radiosensitivity (RS) in ARPC1B-deficient patients to assess whether it can be considered an additional disease trait. First, we performed trio-based next-generation-sequencing studies to obtain the ARPC1B molecular diagnosis in our index case characterized by increased RS, and then we confirmed, using three different methods, an increment of radiosensitivity in all enrolled ARPC1B-deficient patients. In particular, higher levels of chromatid-type aberrations and γH2AX foci, with an increased number of cells arrested in the G2/M-phase of the cell cycle, were found in patients’ cells after ionizing radiation exposition and radiomimetic bleomycin treatment. Overall, our data suggest increased radiosensitivity as an additional trait in ARPC1B deficiency and support the necessity to investigate this feature in ARPC1B patients as well as in other IEI with cytoskeleton defects to address specific clinical follow-up and optimize therapeutic interventions. Frontiers Media S.A. 2022-07-29 /pmc/articles/PMC9372879/ /pubmed/35967303 http://dx.doi.org/10.3389/fimmu.2022.919237 Text en Copyright © 2022 Chiriaco, Ursu, Amodio, Cotugno, Volpi, Berardinelli, Pizzi, Cifaldi, Zoccolillo, Prigione, Di Cesare, Giancotta, Anastasio, Rivalta, Pacillo, Zangari, Fiocchi, Diociaiuti, Bruselles, Pantaleoni, Ciolfi, D’Oria, Palumbo, Gattorno, El Hachem, de Villartay, Finocchi, Palma, Rossi, Tartaglia, Aiuti, Antoccia, Di Matteo and Cancrini https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Chiriaco, Maria
Ursu, Giorgiana Madalina
Amodio, Donato
Cotugno, Nicola
Volpi, Stefano
Berardinelli, Francesco
Pizzi, Simone
Cifaldi, Cristina
Zoccolillo, Matteo
Prigione, Ignazia
Di Cesare, Silvia
Giancotta, Carmela
Anastasio, Elisa
Rivalta, Beatrice
Pacillo, Lucia
Zangari, Paola
Fiocchi, Alessandro G.
Diociaiuti, Andrea
Bruselles, Alessandro
Pantaleoni, Francesca
Ciolfi, Andrea
D’Oria, Valentina
Palumbo, Giuseppe
Gattorno, Marco
El Hachem, Maya
de Villartay, Jean-Pierre
Finocchi, Andrea
Palma, Paolo
Rossi, Paolo
Tartaglia, Marco
Aiuti, Alessandro
Antoccia, Antonio
Di Matteo, Gigliola
Cancrini, Caterina
Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?
title Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?
title_full Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?
title_fullStr Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?
title_full_unstemmed Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?
title_short Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?
title_sort radiosensitivity in patients affected by arpc1b deficiency: a new disease trait?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372879/
https://www.ncbi.nlm.nih.gov/pubmed/35967303
http://dx.doi.org/10.3389/fimmu.2022.919237
work_keys_str_mv AT chiriacomaria radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT ursugiorgianamadalina radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT amodiodonato radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT cotugnonicola radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT volpistefano radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT berardinellifrancesco radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT pizzisimone radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT cifaldicristina radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT zoccolillomatteo radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT prigioneignazia radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT dicesaresilvia radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT giancottacarmela radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT anastasioelisa radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT rivaltabeatrice radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT pacillolucia radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT zangaripaola radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT fiocchialessandrog radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT diociaiutiandrea radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT brusellesalessandro radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT pantaleonifrancesca radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT ciolfiandrea radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT doriavalentina radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT palumbogiuseppe radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT gattornomarco radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT elhachemmaya radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT devillartayjeanpierre radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT finocchiandrea radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT palmapaolo radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT rossipaolo radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT tartagliamarco radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT aiutialessandro radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT antocciaantonio radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT dimatteogigliola radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait
AT cancrinicaterina radiosensitivityinpatientsaffectedbyarpc1bdeficiencyanewdiseasetrait